Medartis announces plans to IPO and list on the SIX Swiss Exchange

Medartis Holding AG, a leading original equipment manufacturer (OEM) specialized in medical devices for internal surgical bone fixation, announces its intention to conduct an initial public offering (IPO) on the SIX Swiss Exchange in the first half of 2018 to finance further growth. Founded in 1997 by Dr. h.c. Thomas Straumann, Medartis has emerged as a company recognized by medical professionals for its innovation in designing and manufacturing fixation system solutions, enabling them to treat small-bone fractures and osteotomies in the lower and upper extremities, as well as of the craniomaxillofacial (CMF) region, for the benefit of their patients. Underwriters for the planned IPO are Zürcher Kantonalbank, Bryan, Garnier & Co and Kepler Cheuvreux.

VISCHER AG is acting as legal counsel to the issuer with Matthias Staehelin (Partner, Corporate) as team leader, Stefan Grieder (Partner, Corporate), Angelo Imperiale (Associate, Corporate), Nadia Tarolli (Partner, Tax), Adrian Briner (Associate, Tax) and Sebastian Wyler (Trainee, Corporate).

Categories: Banking & Finance, Life Sciences, Pharma, Biotech, Deals & Cases